Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy

Pinto, Isabel C.; Nascimento, Luís; Faria, Ângela; Lopes, Márcia; Afonso, Sílvia

Publication

Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy

2016Conference object

dc.contributor.author	Pinto, Isabel C.
dc.contributor.author	Nascimento, Luís
dc.contributor.author	Faria, Ângela
dc.contributor.author	Lopes, Márcia
dc.contributor.author	Afonso, Sílvia
dc.date.accessioned	2018-03-14T17:07:15Z
dc.date.available	2018-03-14T17:07:15Z
dc.date.issued	2016
dc.description.abstract	Erythematosus Systemic Lupus is a chronic inflammatory disease that affects about half a million Europeans, more frequent in the southern countries and fertile women. The therapy adherence in this disease is not well known, particularly in Portugal. Objectives: To characterize the medication therapy of Lupus, estimate the prevalence of therapy adherence and associated factors in Portugal. Methods: This exploratory, cross-sectional and correlational study was based on a questionnaire, with MAT scale (measure of adherence to therapy) validated for the Portuguese population (Delgado & Lima, 2001), applied to 276 members of Patients with Lupus Association, in Portugal. It was used descriptive statistics and Chi-Square test, with a significance level of 5%. Results: The sample consisted mostly of females (96.0%), with an average age of 41 (± 11.46) years old. Antimalarials, antiinflammatory and immunosuppressive drugs are the pharmacotherapeutic groups more used. The prevalence of therapy adherence was 80.2%. Factors associated with Lupus therapy nonadherence are side effects, do not feel improvement, not acceptance, disease in remission and do not feel the need to treat (p<0.05). Conclusions: This study shows a considerable prevalence of Lupus therapy adherence, being several factors associated with nonadherence. It is important the intervention of health professionals to improve therapy adherence for disease control.	pt_PT
dc.description.version	info:eu-repo/semantics/publishedVersion	pt_PT
dc.identifier.citation	Pinto, Isabel C.; Nascimento, Luís ; Faria, Ângela; Lopes, Márcia; Afonso, Sílvia (2016). Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy. In 3rd World Congress of Health Research. Atención Primaria. ISSN 0212-6567. 48 (Esp Cong 1), p. 31-31	pt_PT
dc.identifier.issn	0212-6567
dc.identifier.uri	http://hdl.handle.net/10198/16300
dc.language.iso	eng	pt_PT
dc.peerreviewed	yes	pt_PT
dc.publisher	Elsevier	pt_PT
dc.relation.publisherversion	https://www.journals.elsevier.com/atencion-primaria	pt_PT
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/	pt_PT
dc.subject	Erythematosus systemic lupus	pt_PT
dc.subject	Therapy adherence	pt_PT
dc.title	Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy	pt_PT
dc.type	conference object
dspace.entity.type	Publication
oaire.citation.conferencePlace	Viseu, Portugal	pt_PT
oaire.citation.endPage	31	pt_PT
oaire.citation.issue	48	pt_PT
oaire.citation.startPage	31	pt_PT
oaire.citation.title	3rd World Congress of Health Research	pt_PT
oaire.citation.volume	(Espec Cong 1):25-120	pt_PT
person.familyName	Pinto
person.familyName	Nascimento
person.givenName	Isabel C.
person.givenName	Luís
person.identifier.ciencia-id	851B-247F-C650
person.identifier.ciencia-id	9918-ED25-623E
person.identifier.orcid	0000-0003-4745-6489
person.identifier.orcid	0000-0002-1302-2570
rcaap.rights	openAccess	pt_PT
rcaap.type	conferenceObject	pt_PT
relation.isAuthorOfPublication	751d74ab-e27c-4713-97ba-62cad38d1890
relation.isAuthorOfPublication	9e7bebc0-4460-4f4c-b687-10e34c3b36b9
relation.isAuthorOfPublication.latestForDiscovery	9e7bebc0-4460-4f4c-b687-10e34c3b36b9